Century Therapeutics (IPSC) Change in Acquisitions & Divestments (2020 - 2026)

Century Therapeutics (IPSC) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $28.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 33.8% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $144.9 million (down 16.21% YoY), while the FY2025 annual figure was $159.5 million, down 9.77% from the prior year.
• Change in Acquisitions & Divestments slipped to $28.7 million in Q1 2026 per IPSC's latest filing, from $37.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $110.5 million in Q2 2023 and bottomed at $28.7 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $54.1 million across 5 years, with a median of $48.2 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 719.35% — and 2024, when it tumbled 72.97%.
• Century Therapeutics' Change in Acquisitions & Divestments stood at $52.3 million in 2022, then sank by 44.06% to $29.3 million in 2023, then jumped by 64.59% to $48.2 million in 2024, then declined by 21.51% to $37.8 million in 2025, then slipped by 24.22% to $28.7 million in 2026.
• Business Quant data shows IPSC's Change in Acquisitions & Divestments at $28.7 million in Q1 2026, $37.8 million in Q4 2025, and $35.9 million in Q3 2025.